A Systematic Review and Meta-Analysis of the Efficacy and Safety of Rasagiline or Pramipexole in the Treatment of Early Parkinson’s Disease

<div>Risk of bias table of the included studies. Green, yellow, and red denote low, unclear, and high risk of bias, respectively.</div>

Parkinson’s Disease

fig2

Figure 2

Figure 2: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Rasagiline or Pramipexole in the Treatment of Early Parkinson’s Disease 

Figure 2 | A Systematic Review and Meta-Analysis of the Efficacy and Safety of Rasagiline or Pramipexole in the Treatment of Early Parkinson’s Disease 